In vitro evaluation of antioxidant, anxiolytic and antidepressant-like effects of the Bellis perennis extract

Revista Brasileira de Farmacognosia

Volumn 22, Issue 5, 2012, Pages 1044-1052

  Marques, Thiago Henrique Costa ^a   de Melo, Cássio Herbert Santos ^a   de Freitas, Rivelilson Mendes ^a  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

Author keywords

Antidepressant; Antioxidant; Anxiety; Bellis perennis; Ethanolic extract

Indexed keywords

ALCOHOL; ALKALOID; ANTIDEPRESSANT AGENT; ANTIOXIDANT; ANXIOLYTIC AGENT; BELLIS PERENNIS EXTRACT; FLAVONOID; HYDROXYL RADICAL; IMIPRAMINE; NITRIC OXIDE; PAROXETINE; PHENOL DERIVATIVE; PLANT EXTRACT; RESERPINE; THIOBARBITURIC ACID; UNCLASSIFIED DRUG;

ARTICLE; ASTERACEAE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG SCREENING; FORCED SWIMMING TEST; IN VITRO STUDY; LD 50; MALE; MOUSE; NONHUMAN; SOUTH AMERICA;

EID: 84866950998     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2012005000082     Document Type: Article

References (57)

1. Almeida RN, Falcão ACGM, Diniz RST, Quintans-Júnior LJ, Polari RM, Barbosa-Filho JM, Agra MF, Duarte JC, Ferreira CD, Antoniolli AR, Araújo CC 1999. Metodologia para avaliação de plantas com atividade no sistema nervoso central e alguns dados experimentais. Rev Bras Farm 80: 72-76.
2. Andrade-Cetto A 2009. Ethnobotanical study of the medicinal plants from Tlanchinol, Hidalgo, México. J Ethnopharmacol 122: 163-171.
3. Archer J 1973. Tests for emotionality in rats and mice: a review. Anim Behav 21: 205-235.
4. Asakura W, Matsumoto K, Ohta H, Watanbe H 1993. Effects of alpha 2-adrenergic drugs on REM sleep deprivationinduced increase in swimming activity. Pharmacol Biochem Behav 46: 111-115.
5. Avato P, Tava A 1995. Acetylenes and Terpenoids of Bellis perennis. Phytochemistry 40: 141-7.
6. Baker GB, Coutts RT, Greenshaw AJ 2000. Neurochemical and metabolic aspects of antidepressants: an overview. J Psychiatr Neurosci 25: 481-496.
7. Basu S, Hazra B 2006. Evaluation of nitric oxide scavenging activity, in vitro and ex vivo, of selected medicinal plants traditionally used in inflammatory diseases. Phytotherapy Res 20: 896-900.
8. Campos MM, Fernandes ES, Ferreira J, Bortolanza LB, Santos AR, Calixto JB 2004. Pharmacological and neurochemical evidence for antidepressant-like effects of the herbal product Catuama. Pharmacol Biochem Behav 78: 757-764.
9. Charney EA, Weissman MM 1988. Epidemiology of depressive illness. In J. J. Mann (Ed.), Phenomenology of depressive illness. New York: Human Sciences Press.
10. Costa Jr. JS, Feitosa CM, Citó AMGL, Freitas RM, Henriques JAP, Saffi J 2010. Evaluation of effects of ethanolic extract from Platonia insignis Mart. on pilocarpine-induced seizures. J Biol Sci 10: 747-753.
11. Costa Jr. JS, Ferraz ABF, Filho BAB, Feitosa CM, Citó AMGL, Freitas RM, Saffi J 2011. Evaluation of antioxidant effects in vitro of Garcinielliptone FC (GFC) isolated from Platonia insignis Mart. J Med Plants Res 52: 293-299.
12. Costa M, Brookes SJ, Steele PA, Gibbins I, Burcher E, Kandiah CJ 1996. Neurochemical classifi{ligature}cation of myenteric neurons in the guinea-pig ileum. Neuroscience 75: 949-967.
13. Cox PA 2000. Will tribal knowledge survive the millennium? Science 287: 44-45.
14. Dailly E, Chenu F, Renard CE, Bouin M 2004. Dopamine, depression and antidepressants. Fund Clin Pharmacol 18: 601-607.
15. Desevedavy C, Amoros M, Girre L, Lavaud C, Massiot G 1989. Antifungal agents; in vitro and in vivo antifungal extract from the commen daisy Bellis perennis. J Nat Prod 52: 184-185.
16. De Smet PAGM, Nolen WA 1996. St. John's wort as an antidepressant. Brit Med J 313: 241-242.
17. Danøe R, Bøgh HB 1999. Usage of herbal medicine against helminths in livestock. An old tradition gets its renaissance. World Anim Rev 93: 60-67.
18. Do-Rego JC, Chatenet D, Orta MH, Naudin B, Le Cudennec C, Leprince J, Scalbert E, Vaudry H, Costentin J 2005. Behaviuoral effects of urotensin-II centrally administered in mice. Psychopharmacology 183: 103-117.
19. Ernst E 1995. St. John's wort, an anti-depressant? A systematic, criteria based review. Phytomedicine 2: 67-71.
20. Esterbauer H, Cheeseman KH 1990. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Meth Enzymol 186: 407-421.
21. Flaster T 1996. Ethnobotanical approaches to the discovery of bioactive compounds. Progress in new crops. In: Proceedings of the third National Symposium. ASHS Press, Alexandria.
22. Ferreira PMP, Farias DF, Oliveira JTA, Carvalho A FU 2008. Moringa oleifera: Bioactive compounds and nutritional potential. Rev Nutr 21: 431-437.
23. Ferreira PMP, Carvalho AFFU, Farias DF, Cariolano NG, Melo VMM, Queiroz MGR, Martins AMC, Machado-Neto JG 2009. Larvicidal activity of the water extract of Moringa oleifera seeds against Aedes aegypti and its toxicity upon laboratory animals. An Acad Bras Cienc 81: 207-216.
24. Govaerts R 2001. How many species of seed plants are there? Taxon 50: 1085-1090.
25. Gilbert P 1992. Depression: The evolution of powerlessness. New York: Guilford Press.
26. Greenberg P, Stiglin LE, Finkelstein S 1993. Depression: a neglected major illness. J Clin Psychiat 54: 419-424.
27. Hall CS 1986. Emotional behaviour in the rat: III. The relationship between emotionality and ambulatory activity. J Comp Psychol 22: 345-352.
28. Hamilton MA, Russo RC, Thurston RV 1977. Trimmed Spearman-Karber Method for Estimating Median Lethal Concentrations in Toxicity Bioassays. Environ Sci Technol 11: 714-719.
29. Hansel R, Rimpler H, Schneider G 1992. Hagers Handbuch der Pharmazeutischen Praxis. Berlin: Springer.
30. Henry JP, Gasnier B, Roisin MP, Isambert MF, Scherman D 1987. Molecular pharmacology of the monoamine transporter of the chromaffin granule membrane. Ann N Y Acad Sci 493: 194-206.
31. Hindmarch I 2002. Beyond the monoamine hypothesis: mechanisms, molecules and methods. Eur Psychiat 17: 294-299.
32. Judd LL 1995. Mood disorders in the general population represent an important and world wide public health problem. Int Clin Psychopharm 10: 5-10.
33. Kalueff AV, Wheaton M, Murphy DL 2007. What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res 179: 1-18.
34. Kessler RC, Soukup J, Davis RB, Foster DF, Wilkey SA, Van Rompay MM, Eisenberg DM 2001. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiat 158: 289-294.
35. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiat 62: 617-627.
36. Kumar V 2006. Potential medicinal plants for CNS disorders: an overview. Phytother Res 20: 1023-1035.
37. Lopes GK, Schulman HM, Hermes-Lima M 1999. Polyphenol tannic acid inhibits hydroxyl radical formation from Fenton reaction by complexing ferrous ions. Biochim Biophys Acta 1472: 142-152.
38. Marques THC, Cardoso KMF, Almeida AAC, Tomé AR, Freitas RM 2011. Behavioral studies and histopathological changes in mice pretreated with Bellis perennis in pilocarpine-induced seizures. Bol Latinoam Caribe 10: 338-350.
39. Mello MF, Mello AAF, Kohn R 2007. Epidemiologia da saúde mental no Brasil. Porto Alegre: Artmed.
40. Moltzen EK, Bang-Andersen B 2006. Serotonin reuptake inhibitors: the corner stone in treatment of depression for half a century-a medicinal chemistry survey. Curr Top Med Chem 6: 1801-1823.
41. Munoz RF 1987. Depression prevention research: Conceptual and practical consideration. In Munoz RF (Ed.), Depression prevention: Research directions. New York: Hemisphere Publishing.
42. Porsolt RD, Le Pinchon M, Jalfre M 1977a. Depression: a new animal model sensitive to antidepressant treatments. Nature 266: 730-732.
43. Porsolt RD, Bertin A, Jalfre M 1977b. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacod T 229: 327-336.
44. Porsolt RD, Anton G, Deniel M, Jalfre M 1978. Behavioral despair in rats: a new animal model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379-391.
45. thed. Churchill Livingstone, Edinburgh.
46. Richelson E 1991. Biological basis of depression and therapeutic relevance. J Clin Psychiat 9: 13-20.
47. Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A 2011. Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence. Eur Neuropsycopharm 21: 841-860.
48. Schmidt C, Fronza M, Goettert M, Geller F, Luik S, Flores EMM, Bittencourt CF, Zanetti GD, Heinzmann BM, Laufer S, Merfort I 2009. Biological studies on Brazilian plants used in wound healing. J Ethnopharmacol 122: 523-532.
49. Schippmann U, Leaman DJ, Cunningham AB 2002. Impact of Cultivation and Gathering of Medicinal Plants on Biodiversity: Global Trends and Issues. In Biodiversity and the Ecosystem Approach in Agriculture, Forestry and Fisheries. Satellite Event on the Occasion of the Ninth Regular Session of the Commission on Genetic Resources for Food and Agriculture (FAO), Rome.
50. Schopke T, Wray V, Rzazewska B, Karl H 1991. Bellissaponins BA1 and BA2, acylated saponins from Bellis perennis. Phytochemistry 30: 627-631.
51. Sousa-Brito ARM 1996. How to study the pharmacology of medicinal plants in underdeveloped countries. J Etnopharmacol 54: 131-138.
52. Stahl E 1969. Thin Layer Chromatography: A Laboratory Hand Book. Springer, New York. Substance Abuse and Mental Health Services Administration. 2006. SAMHSA News Release.
53. ndEdn. Springer-Verlag, Berlin, Germany.
54. Wesolowska A, Nikiforuk A, Stachowicz K, Tatarczynska E 2006. Effect of the selective 5-HT(7) receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51: 578-586.
55. World Health Organization 2002. Traditional and Alternative Medicine. Fact sheet NO 271.
56. Yazi{dotless}ci{dotless}oǧlu A, Tuzlaci{dotless} E 1995. Folk Medicinal Plants of Trabzon (Turkey). Mar Üniv Ecz Derg 11: 333-342.
57. Yildiz A, Gonul AS, Tamam L 2002. Mechanism of actions of antidepressants: Beyond the receptors. Bull Clin Psychopharmacog 12: 194-200.